| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |